B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CYP3A7

MOLECULAR TARGET

cytochrome P450 family 3 subfamily A member 7

UniProt: P24462NCBI Gene: 1551205 compounds

CYP3A7 (cytochrome P450 family 3 subfamily A member 7) is targeted by 205 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CYP3A7

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Glyburide1.956
2Ritonavir1.956
3Losartan1.614
4Buspirone1.614
5Disulfiram1.614
6Estrone1.614
7Ezetimibe1.614
8Flumethasone1.614
9Furazolidone1.614
10Maprotiline1.614
11Nitrofurazone1.614
12Ondansetron1.614
13Piperonyl Butoxide1.614
14Testosterone Propionate1.614
15vinblastine sulfate1.614
16Voriconazole1.393
17Amlodipine1.102
18Apigenin 5,7,4'-trihydroxy-flavone,1.102
19Pueraria1.102
20Dehydroepiandrosterone1.102
21Fluoxetine1.102
22Thyroxine1.102
23Methylene Blue1.102
24Mianserin1.102
25Kaempferols1.102
26propyl gallate1.102
27Simvastatin1.102
28vinpocetine1.102
29Vitamin K 21.102
3017-alpha-Hydroxyprogesterone1.102
3117 alpha-Hydroxyprogesterone Caproate Hydroxyprogesterone derivative that acts as1.102
32Abacavir1.102
33Aminopyrine1.102
34Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent1.102
35amlexanox1.102
36Amoxapine1.102
37Anastrozole1.102
38Androstenedione1.102
39Aprepitant1.102
40Aripiprazole1.102
41Artemether1.102
42Atrasentan1.102
43Axitinib1.102
44Beclomethasone1.102
45Betamethasone Valerate1.102
46Bromocriptine1.102
47Bufotenin1.102
48candesartan cilexetil [Supplementary Concept]1.102
49Canrenone1.102
50Carbaryl1.102

Showing top 50 of 205 compounds. Use the BiohacksAI search to explore all CYP3A7 modulators.

About CYP3A7 as a Drug Target

CYP3A7 (cytochrome P450 family 3 subfamily A member 7) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 205 compounds with documented CYP3A7 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CYP3A7 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.